MagVenture Accelerated TMS (aTMS) Therapy System

K260189 · Tonica Elektronik A/S · OBP · May 22, 2026 · Neurology

Device Facts

Record IDK260189
Device NameMagVenture Accelerated TMS (aTMS) Therapy System
ApplicantTonica Elektronik A/S
Product CodeOBP · Neurology
Decision DateMay 22, 2026
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 882.5805
Device ClassClass 2

Regulatory Classification

Identification

A repetitive transcranial magnetic stimulation system is an external device that delivers transcranial repetitive pulsed magnetic fields of sufficient magnitude to induce neural action potentials in the prefrontal cortex to treat the symptoms of major depressive disorder without inducing seizure in patients who have failed at least one antidepressant medication and are currently not on any antidepressant therapy.

Special Controls

*Classification.* Class II (special controls). The special control is FDA's “Class II Special Controls Guidance Document: Repetitive Transcranial Magnetic Stimulation System.” See § 882.1(e) for the availability of this guidance document.

Innolitics

Panel 1

/
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...